Testing effectiveness (Phase 2)WithdrawnNCT03114280
What this trial is testing
Pembrolizumab and Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma (PICH Study)
Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Centre Antoine Lacassagne